Session Information

WCLC 2017

18th World Conference on Lung Cancer

Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan

Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.
Presentation Date(s):
- Oct 15 - 18, 2017
- Total Presentations: 2295
Register to Attend WCLC Return to WCLC 2017 Website Switch to Virtual Meeting
Enter Virtual Meeting Access Code

All Days Saturday
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18

Filter Results:

Show Only CME Accredited Sessions

20203

+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- 22477
  
  +
  
  P1.01-071 - High Dose IVAA Synergy with mEHT in Patients with Stage III-IV NSCLC: A Phase I Study
  
  09:30 - 09:30 | Presenter: Junwen Ou | Author(s): X. Zhu, Y. Lu, C. Zhao, H. Zhang, X. Wang, X. Zhang, T. Zhang, C.L.K. Pang
  Abstract
  
  Loading...
20139

+
MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches
- 15:45 - 17:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:K. Shibuya, Francoise Mornex
- 23768
  
  +
  
  MA 16.14 - c-Met in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Potential Therapeutic Target
  
  17:10 - 17:15 | Presenter: Yaping Xu | Author(s): C. Jiang, S. Han, G. Lin, X. Zhu, J. Feng, G. Zhang, Q. Lin
  Abstract
  
  Loading...
20184

+
P3.05 - Early Stage NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
- 24098
  
  +
  
  P3.05-009 - Hsa_circ_0044013: A Potential Novel Diagnostic Biomarker of Lung Adenocarcinoma
  
  09:30 - 09:30 | Presenter: Shuzhen Wei | Author(s): Y. Chen, S. Han, Y. Wu, X. Wang, Y. Chen, X. Zhu
  Abstract
  
  Loading...
20195

+
P3.16 - Surgery
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Surgery
- 24232
  
  +
  
  P3.16-009 - Reoperation for Hemostasis within 24 Hours Can Get a Better Short-Term Outcome When Indicated after Lung Cancer Surgery
  
  09:30 - 09:30 | Presenter: Qiang Li | Author(s): W. Dai, X. Yang, X. Zhuang, T. Xie, P. Xiao, B. Hu, X. Wang
  Abstract
  
  Loading...
20149

+
MA 20 - Recent Advances in Pulmonology/Endoscopy
- 14:30 - 16:15
- 10/18/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Pulmonology/Endoscopy
- Moderators:C. Lee, S. Sasada
- 24391
  
  +
  
  MA 20.13 - etDNA: Tumor-Derived DNA from Pleural Effusion Supernatant as a Promising Source for NGS-Based Mutation Profiling in Lung Cancer
  
  15:50 - 15:55 | Presenter: Lin Tong | Author(s): N. Ding, J. Li, X. Wang, Y. Zhang, X. Xu, M. Ye, C. Li, H. Zhang, X. Zhu, Z. Zhu, J. Zhou, J. She, J. Zhou, Y.W. Shao, X. Zhang, H. Bao, S. Xu, X. Zhang, Q. Hong, C. Bai, Jie Hu
  Abstract
  
  Loading...

Session Information

WCLC 2017

18th World Conference on Lung Cancer

Enter Virtual Meeting Access Code

+

P1.01 - Advanced NSCLC

+

P1.01-071 - High Dose IVAA Synergy with mEHT in Patients with Stage III-IV NSCLC: A Phase I Study

+

MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches

+

MA 16.14 - c-Met in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Potential Therapeutic Target

+

P3.05 - Early Stage NSCLC

+

P3.05-009 - Hsa_circ_0044013: A Potential Novel Diagnostic Biomarker of Lung Adenocarcinoma

+

P3.16 - Surgery

+

P3.16-009 - Reoperation for Hemostasis within 24 Hours Can Get a Better Short-Term Outcome When Indicated after Lung Cancer Surgery

+

MA 20 - Recent Advances in Pulmonology/Endoscopy

+

MA 20.13 - etDNA: Tumor-Derived DNA from Pleural Effusion Supernatant as a Promising Source for NGS-Based Mutation Profiling in Lung Cancer

Stay Connected